Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ( Mark One ) ☑ ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ΤΟ Commission File Number 001-39273 Lyra Therapeutics , Inc. ( Exact name of Registrant as specified in its Charter ) Delaware ( State or other jurisdiction of incorporation or organization ) 480 Arsenal Way Watertown , MA ( Address of principal executive offices ) 84-1700838 ( I.R.S. Employer Identification No. ) 02472 ( Zip Code ) Registrant's telephone number , including area code : ( 617 ) 393-4600 Securities registered pursuant to Section 12 ( b ) of the Act : Title of each class Common Stock , $ 0.001 par value per share Trading Symbol ( s ) LYRA Name of each exchange on which registered Nasdaq Global Market Securities registered pursuant to Section 12 ( g ) of the Act : None Indicate by check mark if the Registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15 ( d ) of the Act . Yes □ No ☑ Indicate by check mark whether the Registrant : ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the Registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes > No ☐ Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the Registrant was required to submit such files ) . Yes No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , smaller reporting company , or an emerging growth company . See the definitions of “ large accelerated filer , " " accelerated filer , ” “ smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Large accelerated filer Non - accelerated filer Emerging growth company ☐ > ☑ Accelerated filer Smaller reporting company ☐ ☑ If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the Registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes No The aggregate market value of outstanding shares of common stock held by non - affiliates of the Registrant , based on the closing price of the shares of common stock on The Nasdaq Global Market on June 30 , 2020 , the last business day of the Registrant's most recently completed second fiscal quarter , was $ 84,280,762 . For purposes of this disclosure , shares of common stock held by officers and directors of the Registrant and by persons who hold more than 10 % of the Registrant's outstanding common shares have been excluded because such persons may be deemed to be affiliates . This determination of affiliate status is not necessarily conclusive . The number of shares of Registrant's Common Stock , $ 0.001 par value per share , outstanding as of March 1 , 2021 was 12,947,572 . None . DOCUMENTS INCORPORATED BY REFERENCE